SCHEMBL479793

SCHEMBL479793

CCOC(=O)c1ccc2c(c1)NC(=O)C2=CNc1ccc(C(C)(C)N)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.46
RXFP1 Q9HBX9 1/20 0.44
RAB9A P51151 5/20 0.43
MAPT P10636 4/20 0.43
NPC1 O15118 4/20 0.43
SMN1; SMN2 Q16637 3/20 0.43
KMT2A Q03164 3/20 0.43
MEN1 O00255 2/20 0.43
MAPK1 P28482 2/20 0.43
CSF1R P07333 3/20 0.41
KDR P35968 1/20 0.39
TGM2 P21980 1/20 0.39
TP53 P04637 1/20 0.38
THRB P10828 1/20 0.38
AURKB Q96GD4 2/20 0.38
ABL1 P00519 1/20 0.37
RET P07949 1/20 0.37
PDGFRB P09619 1/20 0.37
FGFR1 P11362 1/20 0.37
FLT3 P36888 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2121227 0.90 KMT2A (0.43) ALDH1A1KMT2AMEN1CSF1RTGM2
SCHEMBL3154570 0.88 ALDH1A1 (0.49) ALDH1A1RXFP1RAB9AMAPTNPC1
SCHEMBL3154576 0.88 ALDH1A1 (0.49) ALDH1A1RXFP1RAB9AMAPTNPC1
SCHEMBL479559 0.85 RXFP1 (0.41) RXFP1RAB9AMAPTNPC1SMN1; SMN2
SCHEMBL479427 0.84 ALDH1A1 (0.40) ALDH1A1RXFP1RAB9AMAPTNPC1
SCHEMBL479789 0.83 ALDH1A1 (0.46) ALDH1A1RXFP1RAB9AMAPTNPC1
SCHEMBL479791 0.83 ALDH1A1 (0.46) ALDH1A1RXFP1RAB9AMAPTNPC1
SCHEMBL2567922 0.83 ALDH1A1 (0.46) ALDH1A1RXFP1RAB9AMAPTNPC1
SCHEMBL3148039 0.82 ALDH1A1 (0.48) ALDH1A1RAB9AMAPTNPC1SMN1; SMN2
SCHEMBL3148056 0.82 ALDH1A1 (0.48) ALDH1A1RAB9AMAPTNPC1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9844572-B2 Promotion of neuronal integration in neural stem cell grafts LIFE & BRAIN GMBH (DE) 2017-12-19 US disclosed
EP-2411034-B1 PROMOTION OF NEURONAL INTEGRATION IN NEURAL STEM CELL GRAFTS LIFE & BRAIN GMBH (DE) 2017-07-26 EP disclosed
US-20120093832-A1 PROMOTION OF NEURONAL INTEGRATION IN NEURAL STEM CELL GRAFTS LIFE & BRAIN GMBH (DE) 2012-04-19 US disclosed
EP-2411034-A1 PROMOTION OF NEURONAL INTEGRATION IN NEURAL STEM CELL GRAFTS Life & Brain GmbH (DE) 2012-02-01 EP disclosed
WO-2010108665-A1 PROMOTION OF NEURONAL INTEGRATION IN NEURAL STEM CELL GRAFTS LIFE & BRAIN GMBH (DE) 2010-09-30 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120093832-A1 PROMOTION OF NEURONAL INTEGRATION IN NEURAL STEM CELL GRAFTS DCX, NGF, BDNF ALDH1A1 175/4885RXFP1 2731/4885RAB9A 1246/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.